Effects of metformin on hepatic glucose metabolism

Mark P. Christiansen, Marc K. Hellerstein

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Metformin, dimethylbiguanide, is an agent that has been widely used in the treatment of non-insulin-dependent diabetes mellitus. Its mechanism of action is not dependent on the stimulation of insulin secretion, unlike the sulfonylureas. It is clear that metformin reduces fasting endogenous glucose production rates, which are elevated in non-insulin-dependent diabetes mellitus. Some studies have proposed that metformin reduces endogenous glucose production primarily by reducing gluconeogenesis, whereas others have proposed that gluconeogenesis is not affected. The authors review the literature regarding the effects of metformin on hepatic carbohydrate metabolism.

Original languageEnglish (US)
Pages (from-to)252-255
Number of pages4
JournalCurrent Opinion in Endocrinology and Diabetes
Volume5
Issue number4
StatePublished - 1998

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Fingerprint Dive into the research topics of 'Effects of metformin on hepatic glucose metabolism'. Together they form a unique fingerprint.

  • Cite this

    Christiansen, M. P., & Hellerstein, M. K. (1998). Effects of metformin on hepatic glucose metabolism. Current Opinion in Endocrinology and Diabetes, 5(4), 252-255.